Stock listing

Wave Life Sciences Ltd.

Selected listing: 1U5 · DUS · EUR · DE

Wave Life Sciences Ltd. (Dusseldorf:1U5), Health Technology. Latest release Oct 1, 2026: Wave Life Sciences Announces FDA Feedback Supports Registrational…

1U5:DUSEURDEUpdated October 2, 2026

Ticker: Dusseldorf:1U5
Asset type: Stock
Sector: Health Technology
Industry: Biotechnology
Exchange: Dusseldorf
Currency: EUR

Latest news from Wave Life Sciences Ltd.

Wave Life Sciences Announces FDA Feedback Supports Registrational Pathway for WVE-006 (RNA Editing) in AATD

September 30, 2026

Wave Life Sciences Announces FDA Feedback Supports Registrational Pathway for WVE-006 (RNA Editing) in AATD

October 1, 2026

Wave Life Sciences Announces GSK’s Selection of siRNA program to Transition to GSK for Further Development

September 29, 2026

Wave Life Sciences Announces GSK’s Selection of siRNA program to Transition to GSK for Further Development

September 30, 2026

Wave Life Sciences Initiates Phase 2a Combination Trial of WVE-007 (GalNAc-siRNA) with Tirzepatide for Obesity

September 23, 2026

All Wave Life Sciences Ltd. news →

Events

Replays

Wave Life Sciences Ltd. (WVE) Q2 2026 Earnings Call
Thu, Jul 30, 2026 · 08:30 AM ET
Watch
Wave Life Sciences Ltd. (WVE) Q1 2026 Earnings Call
Tue, Apr 28, 2026 · 08:30 AM ET
Watch
Wave Life Sciences Ltd. (WVE) Q4 2025 Earnings Call
Thu, Feb 26, 2026 · 08:30 AM ET
Watch

Research Wave Life Sciences Ltd.

Wave Life Sciences Ltd. company profile

View the public company page for Wave Life Sciences Ltd. on 6ix.

Wave Life Sciences Ltd. news

Read company news and market updates connected to Wave Life Sciences Ltd..

Wave Life Sciences Ltd. investor events

Find investor webinars, events, and replay context for Wave Life Sciences Ltd..